Literature DB >> 3169388

Perinatal risk factors and minor neurological dysfunction: significance for behaviour and school achievement at nine years.

M Hadders-Algra1, H J Huisjes, B C Touwen.   

Abstract

A prospective study was carried out on 133 neurologically deviant infants, 205 with mild abnormalities and 230 normal newborns to compare behavioural and cognitive development with neonatal and nine-year-old neurological condition. Overtly handicapped children were excluded. Major determinants of school failure were the severity of minor neurological dysfunction (MND) and social class. Main risk factors for distractable and clumsy behaviour were MND classification and male sex; for troublesome behaviour male sex and interval complications after two years of age; and for timid behaviour, family adversity. Definite neonatal neurological deviancy contributed both directly and by its association with MND to problems in behaviour and scholastic abilities. Mild neonatal neurological abnormalities and adverse obstetrical events contributed only indirectly to behavioural and learning problems. Preterm birth (less than 34 weeks) was the sole obstetric variable directly related to some of the outcome variables. The difference between home and school perception of the children's behaviour is emphasized.

Entities:  

Mesh:

Year:  1988        PMID: 3169388     DOI: 10.1111/j.1469-8749.1988.tb04775.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  12 in total

1.  Intellectual psycho-educational and functional status of low birth weight survivors beyond 5 years of age.

Authors:  A Tandon; S Kumari; S Ramji; A Malik; S Singh; V R Nigam
Journal:  Indian J Pediatr       Date:  2000-11       Impact factor: 1.967

2.  Follow up studies during the first five years of life: a pervasive assessment of neurological function.

Authors:  C Amiel-Tison; A Stewart
Journal:  Arch Dis Child       Date:  1989-04       Impact factor: 3.791

Review 3.  Gender differences in the effects of prenatal stress on brain development and behaviour.

Authors:  Marta Weinstock
Journal:  Neurochem Res       Date:  2007-04-04       Impact factor: 3.996

4.  A follow-up study of child psychiatric clinic attenders with minor neurological dysfunction.

Authors:  Margot Völger; Hans-Christoph Steinhausen; Matthias Reitzle
Journal:  Eur Child Adolesc Psychiatry       Date:  1993-07       Impact factor: 4.785

5.  Immune stress in late pregnant rats decreases length of gestation and fecundity, and alters later cognitive and affective behaviour of surviving pre-adolescent offspring.

Authors:  Jason J Paris; Paula J Brunton; John A Russell; Cheryl A Frye
Journal:  Stress       Date:  2011-11       Impact factor: 3.493

6.  Behaviour problems and developmental status of 3-month-old infants in relation to organic and psychosocial risks.

Authors:  G Esser; M Laucht; M Schmidt; W Löffler; A Reiser; R M Stöhr; D Weindrich; H Weinel
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1990

7.  Psychological distress in pregnancy and preterm delivery.

Authors:  M Hedegaard; T B Henriksen; S Sabroe; N J Secher
Journal:  BMJ       Date:  1993-07-24

8.  MRI measurements of the pons and cerebellum in children born preterm; associations with the severity of periventricular leukomalacia and perinatal risk factors.

Authors:  M I Argyropoulou; V Xydis; A Drougia; P I Argyropoulou; M Tzoufi; A Bassounas; S Andronikou; S C Efremidis
Journal:  Neuroradiology       Date:  2003-08-27       Impact factor: 2.804

9.  Neurological abnormalities in young adults born preterm.

Authors:  M Allin; M Rooney; T Griffiths; M Cuddy; J Wyatt; L Rifkin; R Murray
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04       Impact factor: 10.154

10.  Can the Griffiths scales predict neuromotor and perceptual-motor impairment in term infants with neonatal encephalopathy?

Authors:  A L Barnett; A Guzzetta; E Mercuri; S E Henderson; L Haataja; F Cowan; L Dubowitz
Journal:  Arch Dis Child       Date:  2004-07       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.